Adagene ADAG
NASDAQ ADAG
$3.58 -0.11 (-2.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Adagene (ADAG) Share-based Compensation (2020 - 2026)

Adagene (ADAG) posted quarterly Share-based Compensation of $5.2 million for Q4 2025, down 10.27% year-over-year from $5.8 million in Q4 2024, and down 36.47% quarter-over-quarter from $8.2 million in Q2 2025.

Analysis

Adagene (ADAG) Share-based Compensation (2020 - 2026) Analysis & Trends

Adagene (ADAG) has reported Share-based Compensation for 6 consecutive years, with $5.2 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Share-based Compensation fell 10.27% year-over-year to $5.2 million; the TTM figure through Dec 2025 stood at $5.2 million (down 10.27% YoY), while the FY2025 annual figure was $5.2 million, down 10.27% from the prior year.
  • Share-based Compensation fell to $5.2 million in Q4 2025 per ADAG's latest filing, from $8.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $30.6 million in Q4 2021 and bottomed at $5.2 million in Q4 2025.
  • Historically, Share-based Compensation has averaged $14.9 million across 5 years, with a median of $14.1 million in 2024.
  • Annual changes were most pronounced in 2021 — Share-based Compensation retreated 10.23% — and 2024, when it tumbled 65.32%.
  • Adagene's Share-based Compensation stood at $30.6 million in 2021, then fell by 22.78% to $23.6 million in 2022, then dropped by 29.52% to $16.7 million in 2023, then sank by 65.32% to $5.8 million in 2024, then slipped by 10.27% to $5.2 million in 2025.
  • Business Quant data shows ADAG's Share-based Compensation at $5.2 million in Q4 2025, $8.2 million in Q2 2025, and $5.8 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Adagene 211.24 Mn 211.24 Mn - 6.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.86 Mn
Dec 31, 2025 5.18 Mn
Jun 30, 2025 8.16 Mn
Dec 31, 2024 5.78 Mn
Jun 30, 2024 14.11 Mn
Dec 31, 2023 16.66 Mn
Jun 30, 2023 7.62 Mn
Dec 31, 2022 23.64 Mn
Dec 31, 2021 30.61 Mn
Dec 31, 2020 34.10 Mn